Charles H Earnshaw

12PUBLICATIONS
35CO-AUTHORS
Artificial life and complex adaptive systemsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMigration, asylum and refugee law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2026
Real-world diagnostic performance of artificial intelligence in skin cancer screening.

|Oct 14, 2025
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.

Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang

|Aug 06, 2025
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.

Charles H Earnshaw, Poppy Dunn, Shih-Chieh Chiang

|Apr 20, 2022
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.

Charlotte R Bell, Victoria S Pelly, Agrin Moeini

|May 13, 2021
Ultraviolet light-induced collagen degradation inhibits melanoma invasion.

Timothy Budden, Caroline Gaudy-Marqueste, Andrew Porter

|Nov 20, 2018
A retrospective study comparing the length of admission of medium secure unit patients admitted in the three decades since 1985.

Charles H Earnshaw, Lucy Shaw, Deepu Thomas

Pageof 2

Frequent Collaborators

2 joint publications

Santiago Zelenay

2 joint publications

Eduardo Bonavita

2 joint publications

Maria A Koufaki

2 joint publications

Charlotte R Bell